DNAH8 and neoplasm: Interestingly, novobiocin has recently been studied for its anti-tumour effects as a result of its strong binding to the ATPase domain in DNA polymerase θ, with specific activity over other eukaryotic proteins bearing homologous ATPase domains including HSP90, suggesting a potential repurposing route for the drug [47].